Splanchnic arterial doppler parameters in portal hypertension
β Scribed by Marco Valgimigli; Fabio Piscaglia; Stefano Gaiani; Luigi Bolondi
- Publisher
- John Wiley and Sons
- Year
- 1999
- Tongue
- English
- Weight
- 16 KB
- Volume
- 29
- Category
- Article
- ISSN
- 0270-9139
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
The splanchnic venous system was examined by real-time ultrasonography in 46 patients with cirrhosis and documented portal hypertension and in 32 healthy subjects. Patients with portal hypertension had increased diameter of the splanchnic (portal, splenic, and superior mesenteric) veins (76% of pati
Other abbreviation used rn the text: CGRP, calcitonin gene-related peptide. This work was supported by grants from Direccion General de Investigacion Cientifica y Tecnica (PM91-0227, PB90-0994). The CGRP experiments were conducted with support from the Austrian Science Foundation (grant P9473-MED).
Portal hypertension is associated with splanchnic hyperemia and increased plasma levels of prostacyclin. Recently, nitric oxide was proposed as a mediator of this arterial vasodilatation. We hypothesized that portal hypertension alters the relative contribution of prostacyclin and nitric oxide to sp
Alcoholic liver disease is frequently accompanied by portal hypertension. We have previously shown that alcohol intake in awake, unrestrained rats is followed by an increase in portal tributary blood flow. In this study, the effect of ethanol on splanchnic hemodynamics in rats with portal hypertensi
Portal hypertension (PHT) is characterized by increased portal pressure caused in part by a reduction in mesenteric vascular resistance. The aim of this study was to evaluate the role of endothelin (ET) and specific ET receptors in maintaining the vasculopathy of PHT. PHT was created in Sprague-Dawl